158 related articles for article (PubMed ID: 9677021)
1. Intrabronchial surfactant application in cases of inhalation injury: first results from patients with severe burns and ARDS.
Pallua N; Warbanow K; Noah EM; Machens HG; Poets C; Bernhard W; Berger A
Burns; 1998 May; 24(3):197-206. PubMed ID: 9677021
[TBL] [Abstract][Full Text] [Related]
2. [Intrabronchial surfactant administration in inhalation trauma of severely burned patients with ARDS. Initial case reports].
Pallua N; Warbanow K; Machens HG; Poets C; Berger A
Unfallchirurg; 1997 May; 100(5):363-70. PubMed ID: 9297244
[TBL] [Abstract][Full Text] [Related]
3. Surfactant therapy for acute respiratory distress in severe pediatric burn injury: a case series.
Sen S; Tung K; Palmieri T; Greenhalgh D
J Burn Care Res; 2012; 33(2):e88-91. PubMed ID: 22002204
[TBL] [Abstract][Full Text] [Related]
4. Bronchoscopic administration of bovine natural surfactant in ARDS and septic shock: impact on biophysical and biochemical surfactant properties.
Günther A; Schmidt R; Harodt J; Schmehl T; Walmrath D; Ruppert C; Grimminger F; Seeger W
Eur Respir J; 2002 May; 19(5):797-804. PubMed ID: 12030716
[TBL] [Abstract][Full Text] [Related]
5. Surfactant treatment in a pediatric burn patient with respiratory failure.
Tortorolo L; Chiaretti A; Piastra M; Viola L; Polidori G
Pediatr Emerg Care; 1999 Dec; 15(6):410-1. PubMed ID: 10608328
[TBL] [Abstract][Full Text] [Related]
6. Bronchoscopic surfactant administration in patients with severe adult respiratory distress syndrome and sepsis.
Walmrath D; Günther A; Ghofrani HA; Schermuly R; Schneider T; Grimminger F; Seeger W
Am J Respir Crit Care Med; 1996 Jul; 154(1):57-62. PubMed ID: 8680699
[TBL] [Abstract][Full Text] [Related]
7. Bronchoscopic administration of bovine natural surfactant in ARDS and septic shock: impact on gas exchange and haemodynamics.
Walmrath D; Grimminger F; Pappert D; Knothe C; Obertacke U; Benzing A; Günther A; Schmehl T; Leuchte H; Seeger W
Eur Respir J; 2002 May; 19(5):805-10. PubMed ID: 12030717
[TBL] [Abstract][Full Text] [Related]
8. [Surfactant replacement therapy increases life-span of patients with acute respiratory distress syndrome].
Potapov AL; Novikov NIu; Tumanskiĭ VA; Babanin AA
Klin Khir; 2013 Feb; (2):57-9. PubMed ID: 23705485
[TBL] [Abstract][Full Text] [Related]
9. High frequency oscillatory ventilation in burn patients with the acute respiratory distress syndrome.
Cartotto R; Ellis S; Gomez M; Cooper A; Smith T
Burns; 2004 Aug; 30(5):453-63. PubMed ID: 15225911
[TBL] [Abstract][Full Text] [Related]
10. Ultrasonic nebulization for efficient delivery of surfactant in a model of acute lung injury. Impact on gas exchange.
Schermuly R; Schmehl T; Günther A; Grimminger F; Seeger W; Walmrath D
Am J Respir Crit Care Med; 1997 Aug; 156(2 Pt 1):445-53. PubMed ID: 9279222
[TBL] [Abstract][Full Text] [Related]
11. Combined surfactant therapy and inhaled nitric oxide in rabbits with oleic acid-induced acute respiratory distress syndrome.
Zhu GF; Sun B; Niu SF; Cai YY; Lin K; Lindwall R; Robertson B
Am J Respir Crit Care Med; 1998 Aug; 158(2):437-43. PubMed ID: 9700118
[TBL] [Abstract][Full Text] [Related]
12. Dose-response comparisons of five lung surfactant factor (LSF) preparations in an animal model of adult respiratory distress syndrome (ARDS).
Häfner D; Beume R; Kilian U; Krasznai G; Lachmann B
Br J Pharmacol; 1995 Jun; 115(3):451-8. PubMed ID: 7582456
[TBL] [Abstract][Full Text] [Related]
13. [Treatment of severe inhalation injury with endotracheal infusion of exogenous pulmonary surfactant].
Luo Q; Liu Z; Yang Z
Zhonghua Shao Shang Za Zhi; 2000 Jun; 16(3):145-6. PubMed ID: 11876858
[TBL] [Abstract][Full Text] [Related]
14. Exogenous surfactant in paediatric Acute Lung Injury and Acute Respiratory Distress Syndrome.
Playfor SD; Nootigattu VK
Curr Drug Saf; 2006 May; 1(2):159-68. PubMed ID: 18690927
[TBL] [Abstract][Full Text] [Related]
15. [Surfactant-BL and inhaled nitric oxide in acute respiratory distress syndrome in cardiac surgical patients].
Kozlov IA; Poptsov VN
Anesteziol Reanimatol; 2005; (6):38-41. PubMed ID: 16499105
[TBL] [Abstract][Full Text] [Related]
16. Patients with ARDS show improvement but not normalisation of alveolar surface activity with surfactant treatment: putative role of neutral lipids.
Markart P; Ruppert C; Wygrecka M; Colaris T; Dahal B; Walmrath D; Harbach H; Wilhelm J; Seeger W; Schmidt R; Guenther A
Thorax; 2007 Jul; 62(7):588-94. PubMed ID: 17287298
[TBL] [Abstract][Full Text] [Related]
17. Exogenous natural surfactant for treatment of acute lung injury and the acute respiratory distress syndrome.
Kesecioglu J; Beale R; Stewart TE; Findlay GP; Rouby JJ; Holzapfel L; Bruins P; Steenken EJ; Jeppesen OK; Lachmann B
Am J Respir Crit Care Med; 2009 Nov; 180(10):989-94. PubMed ID: 19713451
[TBL] [Abstract][Full Text] [Related]
18. Acute respiratory distress syndrome is as important as inhalation injury for the development of respiratory dysfunction in major burns.
Steinvall I; Bak Z; Sjoberg F
Burns; 2008 Jun; 34(4):441-51. PubMed ID: 18243566
[TBL] [Abstract][Full Text] [Related]
19. Adult respiratory distress syndrome and artificial surfactant replacement in the pediatric patient.
Perez-Benavides F; Riff E; Franks C
Pediatr Emerg Care; 1995 Jun; 11(3):153-5. PubMed ID: 7651868
[TBL] [Abstract][Full Text] [Related]
20. Factors influencing efficacy of exogenous surfactant in acute lung injury.
Lewis JF; Veldhuizen RA
Biol Neonate; 1995; 67 Suppl 1():48-60. PubMed ID: 7647158
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
